Ibrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Disease

dc.authoridSevindik, Omur Gokmen/0000-0001-9636-4113
dc.authoridUzay, Ant/0000-0003-1381-4188
dc.authoridKAYA, Emin/0000-0001-8605-8497
dc.authoridcivriz bozdağ, sinem/0000-0001-8359-7794
dc.authoridYüksel, Meltem Kurt/0000-0003-0369-299X
dc.authoridCengiz Seval, Guldane/0000-0001-9433-2054
dc.authorwosidSevindik, Omur Gokmen/AAD-5452-2021
dc.authorwosidUzay, Ant/KIV-9553-2024
dc.authorwosidDeveci, Burak/AAU-6465-2020
dc.authorwosidKAYA, Emin/W-2951-2017
dc.authorwosidilhan, osman/ABC-8182-2021
dc.authorwosidcivriz bozdağ, sinem/AAQ-4752-2020
dc.authorwosidYüksel, Meltem Kurt/A-3856-2019
dc.contributor.authorIlhan, Osman
dc.contributor.authorSeval, Guldane Cengiz
dc.contributor.authorUzay, Ant
dc.contributor.authorKaya, Emin
dc.contributor.authorOzturk, Zubeyde Nur
dc.contributor.authorDeveci, Burak
dc.contributor.authorYavasoglu, Irfan
dc.date.accessioned2024-08-04T20:58:59Z
dc.date.available2024-08-04T20:58:59Z
dc.date.issued2020
dc.departmentİnönü Üniversitesien_US
dc.descriptionTransplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR -- FEB 19-23, 2020 -- Orlando, FLen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Transplantat & Cellular Therapy,CIBMTRen_US
dc.identifier.endpageS191en_US
dc.identifier.issn1083-8791
dc.identifier.issn1523-6536
dc.identifier.issue3en_US
dc.identifier.startpageS191en_US
dc.identifier.urihttps://hdl.handle.net/11616/103340
dc.identifier.volume26en_US
dc.identifier.wosWOS:000516887900280en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofBiology of Blood and Marrow Transplantationen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleIbrutinib As a Promising Treatment for Pulmonary Complications Due to Refractory Chronic Graft Versus Host Diseaseen_US
dc.typeConference Objecten_US

Dosyalar